Russian Federation vs Saudi Arabia: Previously treated cases tested for RR-/MDR-TB
Russian Federation
98.0%
in 2024
Saudi Arabia
98.0%
in 2024
Russian Federation rank
58th
Saudi Arabia rank
58th
Previously treated cases tested for RR-/MDR-TB over time
- Russian Federation
- Saudi Arabia
How they compare
Russian Federation currently reports 98.0% against 98.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 5 times across 12 shared years of data; in 2013 it was Russian Federation ahead.
Russian Federation ranks 58th and Saudi Arabia ranks 58th of 180 countries.
Russian Federation has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Russian Federation | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.3% | 52.2% | 4.1% | Russian Federation |
| 2020s | 95.8% | 70.6% | 25.2% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Russian Federation or Saudi Arabia?
- Russian Federation, at 98.0% against 98.0% in Saudi Arabia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Russian Federation and Saudi Arabia?
- 0.0%, with Russian Federation ahead.
- How many years of comparable data are there for Russian Federation and Saudi Arabia?
- 12 years are reported by both, from 2013 to 2024.
- How do Russian Federation and Saudi Arabia rank globally for previously treated cases tested for rr-/mdr-tb?
- Russian Federation ranks 58th and Saudi Arabia ranks 58th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.